arrow
Y

Yasuyuki Kawamoto

hokkaido university
H指数:18
被引数:1,877

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Implications of Polyploid Giant Cancer Cells in Solid Tumors: Biology, Diagnosis, and Therapeutic Considerations

实体瘤中多倍体巨癌细胞的治疗意义:生物学、诊断和治疗考量

Cancers
IF4.4
2026-06-010
OA
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903)

雷莫芦单抗和多西他赛作为晚期胃癌二线治疗的II期临床试验(HGCSG 1903)

2026-05-040
OAAI
Impact of ERCC1 on the outcomes of chemotherapy in advanced biliary tract cancer

ERCC1对晚期胆道癌化疗效果的影响

2025-09-300
OA
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis

FOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较:一项倾向性评分匹配分析

2025-08-300
PRE
Normal tissue complication probability model for severe radiation-induced lymphopenia in patients with pancreatic cancer treated with concurrent chemoradiotherapy
2025-01-010
OAAI
5-Fluorouracil metabolic pathway genes predict recurrence risk following adjuvant S-1 therapy: Results of an ancillary analysis from a phase III trial of resected biliary tract cancer (JCOG1202A1)
2024-09-250
PRE
Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer

循环肿瘤DNA中BRCA和ATM突变状态在晚期胰腺癌治疗选择中的临床应用

2024-08-280
PRE
A multicenter, prospective, phase II trial of second-line aflibercept plus FOLFIRI in patients with metastatic colorectal cancer refractory to an anti-EGFR antibody: HGCSG1801
2024-08-142
OA
Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)
2023-02-173
OAAI
Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer
2023-02-1310
PRE